Assessment of prenatal ovarian and serum estrogen concentration in Nili-Ravi buffalo fetus

2021 ◽  
Vol 10 (4) ◽  
Author(s):  
Momen Khan
2020 ◽  
Vol 40 (11) ◽  
pp. NP613-NP618
Author(s):  
Bilsev Ince ◽  
Munur Selcuk Kendir ◽  
Ibrahim Kilinc ◽  
Mustafa Cihat Avunduk ◽  
Mehmet Dadaci ◽  
...  

Abstract Background Although some studies in the literature report that autologous and homologous platelet-rich plasma (PRP) can be employed in the treatment of androgenic alopecia (AGA), no study, to the authors’ knowledge, has examined the estrogen concentration of prepared PRP. Objectives The authors aimed to determine the presence of estrogen in PRP and to investigate the effect of estrogen concentration of PRP on AGA treatment. Methods Between 2017 and 2018, 30 male patients with hair loss complaints were included in this prospective study. Autologous PRP was injected in patients in Group 1. Homologous PRP with high estrogen levels was injected in the patients in Group 2. PRP was injected in both groups 4 times at 0, 1, 3, and 6 months. The obtained photographs were evaluated and hair densities of each patient at controls were calculated. Results The mean estrogen level measured in PRP was statistically significantly higher in Group 2. In both groups, the increase in hair density was observed from the first month, but this increase was statistically significantly higher in all controls in Group 2. In Group 2, there was a statistically significant increase in the 1st and 3rd months compared with the previous control, but there was no difference between the 6th and 12th months and the 3rd month. Conclusions Increased hair density is greater and earlier in the group receiving estrogen-rich PRP than in the group utilizing autologous PRP. The authors think that estrogen-rich PRP may be employed in the treatment of AGA in the presence of an appropriate donor. Level of Evidence: 2


1979 ◽  
Vol 58 (12) ◽  
pp. 2370-2370 ◽  
Author(s):  
Michael Z. Marder ◽  
Usha Joshi ◽  
Irwin D. Mandel

2006 ◽  
Vol 54 (10) ◽  
pp. 87-93 ◽  
Author(s):  
T. Hashimoto ◽  
K. Takahashi ◽  
T. Murakami

Since the natural estrogens 17 β-estradiol (E2) and estron (E1), and the synthetic estrogen 17 α-ethynyl estradiol (EE2) have strong endocrine disrupting effects and the tendency to persist in effluent from wastewater treatment plants, effective measures are needed to remove them from wastewater. In this research, to gain an understanding of the characteristics of estrogen decomposition by ozonation, experiments were conducted using effluent from an actual wastewater treatment plant. In this experiment, estrogen was added to effluent at a concentration of 200 ng/l and 20 ng/l before the ozonation experiments. The results showed 90% or more of estrogen concentration and estrogenic activity of E2, E1 and EE2 to be removed at an ozone dose of 1 mg/l. At an ozone dose of 3 mg/l, the estrogen concentration and estrogenic activity of E2, E1 and EE2 in the treated water fell below the detection limit. The removal rate was not influenced by the kind of estrogen. No generation of byproducts with estrogenic activity was observed. The authors conclude that estrogen in secondary treated wastewater can be almost entirely removed at the practical ozone dose rate applied for the purpose of disinfection, which is up to about 5 mg/l.


2009 ◽  
Vol 28 (11) ◽  
pp. 2263 ◽  
Author(s):  
Nan Xu ◽  
Andrew C. Johnson ◽  
Monika D. Jürgens ◽  
Neville R. Llewellyn ◽  
Nick P. Hankins ◽  
...  

1988 ◽  
Vol 65 (2) ◽  
pp. 525-533 ◽  
Author(s):  
S. M. Fortney ◽  
W. S. Beckett ◽  
A. J. Carpenter ◽  
J. Davis ◽  
H. Drew ◽  
...  

Bed rest (BR) is associated with a decrease in plasma volume (PV), which may contribute to the impaired orthostatic and exercise tolerances seen immediately after BR. The purpose of this study was to determine whether increases in blood estrogen concentration, either during normal menstrual cycles or during exogenous estrogen administration, would attenuate this loss of PV. Nineteen healthy women (21-39 yr of age) completed the study. Twelve women underwent duplicate 11-day BR without estrogen supplementation. PV decreased significantly (P less than or equal to 0.01) during both BR's, from 2,531 +/- 113 to 2,027 +/- 102 ml during BR1 and from 2,445 +/- 115 to 2,244 +/- 96 ml during BR2. The women who began BR in the periovulatory stage of the menstrual cycle (n = 3), a time of elevated endogenous estrogens, had a transient delay in loss of PV during the first 5 days of BR. Women who began BR during other stages of the menstrual cycle (n = 17) showed the established trend to decrease PV primarily during the first few days of BR. Seven additional women underwent a single 12-day BR while taking estrogen supplementation (1.25 mg/day premarin). PV decreased during the first 4-5 days of BR, then returned toward the pre-BR level during the remainder of the BR (pre-BR PV, 2,525 +/- 149 ml; post-BR PV, 2,519 +/- 162 ml). Thus menstrual fluctuations in endogenous estrogens appear to have only small transient effects on the loss of PV during BR, whereas exogenous estrogen supplementation significantly attenuates PV loss.


PLoS ONE ◽  
2016 ◽  
Vol 11 (8) ◽  
pp. e0160910 ◽  
Author(s):  
Koei Ikeda ◽  
Kenji Shiraishi ◽  
Ayaka Yoshida ◽  
Yusuke Shinchi ◽  
Mune Sanada ◽  
...  

2003 ◽  
Vol 267 (3) ◽  
pp. 134-138 ◽  
Author(s):  
I. Mihmanli ◽  
Veli Mihmanli ◽  
Fatih Kantarci ◽  
Mehmet Sait Albayram ◽  
Kadir Atakir ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document